NFKB1 and rheumatoid arthritis: Dexamethasone, a glucocorticoid commonly used to treat inflammatory diseases such as RA, is known to inhibit NF-κB signaling and the production of proinflammatory cytokines by promoting the overexpression of IκBα [207,208].